Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2021 Filed Mar 5, 2022 01:11 UTC |
Cunningham Steven EChief Financial Officer
|
GrantStock Option (right to buy) with limited SAR · Derivative | 11,272 | $0.00 Strike: $35.75 | $0.00 |
DisclosureSEC source: 0000899243-22-009559 · doc4.xml · derivative · entry 2 Cunningham Steven E · CIK 0001575452 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,299 Underlying: Common stock, par value $0.00001 per share · 11,272 shares Expires 2028-11-04 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025. Read SEC document |
| November 04, 2021 Filed Mar 5, 2022 00:46 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
GrantStock Option (right to buy) with limited SAR · Derivative | 4,580 | $0.00 Strike: $35.75 | $0.00 |
DisclosureSEC source: 0000899243-22-009517 · doc4.xml · derivative · entry 3 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,981 Underlying: Common stock, par value $0.00001 per share · 4,580 shares Expires 2028-11-04 F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F6 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 15:56 UTC |
Chartier KirkChief Marketing Officer
|
SaleCommon stock, par value $0.00001 per share | 8,719 | $33.55 | $292,519.83 |
DisclosureSEC source: 0000899243-21-042323 · doc4.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,618 F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Chartier's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.72 to $34.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| October 15, 2021 Filed Mar 5, 2022 00:46 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
SaleCommon stock, par value $0.00001 per share | 1,430 | $36.59 | $52,324.70 |
DisclosureSEC source: 0000899243-22-009517 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,127 F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/18/2021 adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| October 09, 2021 Filed Oct 12, 2021 21:36 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
Tax withholdingCommon stock, par value $0.00001 per share | 656 | $36.06 | $23,655.36 |
DisclosureSEC source: 0000899243-21-039893 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,557 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on October 9, 2021. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of Mr. Rahilly. F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person. F3 · balance_after: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on October 9, 2021. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of Mr. Rahilly. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 10:05 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 20,953 | $35.80 | $750,023.11 |
DisclosureSEC source: 0000899243-21-039779 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,088 F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.52 to $36.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 16:09 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
SaleCommon stock, par value $0.00001 per share | 4,290 | $35.00 | $150,150.00 |
DisclosureSEC source: 0000899243-21-038159 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,213 F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/18/2021 adopted by the reporting person. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 19:56 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 4,587 | $32.70 | $149,974.26 |
DisclosureSEC source: 0000899243-21-035653 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,041 F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.19 to $32.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 16:03 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 4,736 | $31.67 | $150,004.75 |
DisclosureSEC source: 0000899243-21-033216 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,628 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 03, 2021 Filed Mar 5, 2022 01:08 UTC |
Chartier KirkChief Strategy Officer
|
GrantStock Option (right to buy) with limited SAR · Derivative | 9,256 | $0.00 Strike: $31.98 | $0.00 |
DisclosureSEC source: 0000899243-22-009553 · doc4.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,052 Underlying: Common stock, par value $0.00001 per share · 9,256 shares Expires 2028-08-03 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025. Read SEC document |
| August 03, 2021 Filed Mar 5, 2022 01:04 UTC |
Fisher DavidDirector · Chief Executive Officer
|
GrantStock Option (right to buy) with limited SAR · Derivative | 42,466 | $0.00 Strike: $31.98 | $0.00 |
DisclosureSEC source: 0000899243-22-009545 · doc4.xml · derivative · entry 2 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217,948 Underlying: Common stock, par value $0.00001 per share · 42,466 shares Expires 2028-08-03 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025. Read SEC document |
| August 03, 2021 Filed Mar 5, 2022 01:11 UTC |
Cunningham Steven EChief Financial Officer
|
GrantStock Option (right to buy) with limited SAR · Derivative | 11,087 | $0.00 Strike: $31.98 | $0.00 |
DisclosureSEC source: 0000899243-22-009559 · doc4.xml · derivative · entry 1 Cunningham Steven E · CIK 0001575452 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,027 Underlying: Common stock, par value $0.00001 per share · 11,087 shares Expires 2028-08-03 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025. Read SEC document |
| August 03, 2021 Filed Mar 5, 2022 00:46 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
GrantStock Option (right to buy) with limited SAR · Derivative | 4,504 | $0.00 Strike: $31.98 | $0.00 |
DisclosureSEC source: 0000899243-22-009517 · doc4.xml · derivative · entry 2 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,401 Underlying: Common stock, par value $0.00001 per share · 4,504 shares Expires 2028-08-03 F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025. Read SEC document |
| July 09, 2021 Filed Jul 12, 2021 20:21 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 4,445 | $33.75 | $150,017.42 |
DisclosureSEC source: 0000899243-21-028103 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,364 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.21 to $34.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:23 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
SaleCommon stock, par value $0.00001 per share | 1,430 | $35.01 | $50,064.30 |
DisclosureSEC source: 0000899243-21-024099 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,503 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/21/2021 adopted by the reporting person. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 16:16 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 8,444 | $35.52 | $299,945.23 |
DisclosureSEC source: 0000899243-21-024090 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,809 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 17, 2021 Filed May 18, 2021 16:21 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
SaleCommon stock, par value $0.00001 per share | 1,430 | $36.51 | $52,209.30 |
DisclosureSEC source: 0000899243-21-019737 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,933 F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/21/2021 adopted by the reporting person. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:53 UTC |
CARNAHAN ELLENDirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019234 · doc4.xml · nonDerivative · entry 1 CARNAHAN ELLEN · CIK 0001037175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,170 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:56 UTC |
GOODYEAR WILLIAM MDirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019237 · doc4.xml · nonDerivative · entry 1 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,955 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:44 UTC |
TEBBE MARKDirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019221 · doc4.xml · nonDerivative · entry 1 TEBBE MARK · CIK 0001131785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,495 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:50 UTC |
McGowan MarkDirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019231 · doc4.xml · nonDerivative · entry 1 McGowan Mark · CIK 0001482192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,487 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:52 UTC |
KAPLAN GREGG A.Director
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019233 · doc4.xml · nonDerivative · entry 1 KAPLAN GREGG A. · CIK 0001461299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,355 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:57 UTC |
FEEHAN DANIEL RDirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019239 · doc4.xml · nonDerivative · entry 1 FEEHAN DANIEL R · CIK 0001188234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,142 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:45 UTC |
RICE LINDA JOHNSONDirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019223 · doc4.xml · nonDerivative · entry 1 RICE LINDA JOHNSON · CIK 0001188735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,445 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:49 UTC |
Gray James ADirector
|
GrantCommon stock, par value $0.00001 per share | 3,966 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019228 · doc4.xml · nonDerivative · entry 1 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,495 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 10, 2021 Filed May 12, 2022 22:12 UTC |
GOODYEAR WILLIAM MDirector
|
GrantCommon stock, par value $0.00001 per share | 4,180 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017822 · doc4.xml · nonDerivative · entry 1 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,175 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 10, 2023, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 10, 2021 Filed May 12, 2022 22:11 UTC |
FEEHAN DANIEL RDirector
|
GrantCommon stock, par value $0.00001 per share | 4,180 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017821 · doc4.xml · nonDerivative · entry 1 FEEHAN DANIEL R · CIK 0001188234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,322 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 10, 2023, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 15:38 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 9,907 | $35.33 | $350,034.12 |
DisclosureSEC source: 0000899243-21-018296 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,253 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.69 to $35.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 28, 2021 Filed Apr 29, 2021 16:54 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
SaleCommon stock, par value $0.00001 per share | 1,430 | $35.00 | $50,050.00 |
DisclosureSEC source: 0000899243-21-017345 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,363 F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 19:47 UTC |
Chartier KirkChief Marketing Officer
|
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative | 35,289 | $21.34 Strike: $34.25 | $753,067.26 |
DisclosureSEC source: 0000899243-21-015526 · doc4.xml · derivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,796 Underlying: Common stock, par value $0.00001 per share · 35,289 shares Expires 2026-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan, dated March 9, 2021, adopted by the reporting person. F6 · derivative.exercise_date: The options vested or will vest in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 12, 2020, February 12, 2021 and February 12, 2022. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 19:47 UTC |
Chartier KirkChief Marketing Officer
|
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative | 69,275 | $23.04 Strike: $34.25 | $1,596,096.00 |
DisclosureSEC source: 0000899243-21-015526 · doc4.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,085 Underlying: Common stock, par value $0.00001 per share · 69,275 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan, dated March 9, 2021, adopted by the reporting person. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 19:47 UTC |
Chartier KirkChief Marketing Officer
|
SaleCommon Stock, par value $0.00001 | 3,623 | $34.02 | $123,265.33 |
DisclosureSEC source: 0000899243-21-015526 · doc4.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,337 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan, dated March 9, 2021, adopted by the reporting person. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 21:18 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 27,951 | $35.78 | $999,947.03 |
DisclosureSEC source: 0000899243-21-015117 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,160 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:05 UTC |
Fisher DavidDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative | 98,185 | $23.04 Strike: $39.63 | $2,262,182.40 |
DisclosureSEC source: 0000899243-21-011930 · doc4.xml · derivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175,482 Underlying: Common stock, par value $0.00001 per share · 98,185 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:42 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 5,000 | $39.70 | $198,500.00 |
DisclosureSEC source: 0000899243-21-011587 · doc4.xml · nonDerivative · entry 2 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 10,000 Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:42 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 5,000 | $39.75 | $198,750.00 |
DisclosureSEC source: 0000899243-21-011587 · doc4.xml · nonDerivative · entry 1 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 15,000 Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 20:29 UTC |
KAPLAN GREGG A.Director
|
SaleCommon stock, par value $0.00001 per share | 8,703 | $36.50 | $317,659.50 |
DisclosureSEC source: 0000899243-21-010962 · doc4.xml · nonDerivative · entry 1 KAPLAN GREGG A. · CIK 0001461299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,389 Read SEC document |
| March 05, 2021 Filed Mar 5, 2021 22:38 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative | 8,799 | $23.04 Strike: $34.39 | $202,728.96 |
DisclosureSEC source: 0000899243-21-010164 · doc4.xml · derivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,897 Underlying: Common stock, par value $0.00001 per share · 8,799 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.14 to $34.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017. Read SEC document |
| March 04, 2021 Filed Mar 5, 2022 01:04 UTC |
Fisher DavidDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative | 70,000 | $23.04 Strike: $32.95 | $1,612,800.00 |
DisclosureSEC source: 0000899243-22-009545 · doc4.xml · derivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,273,667 Underlying: Common stock, par value $0.00001 per share · 70,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.56 to $33.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:05 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 2,854 | $32.47 | $92,669.38 |
DisclosureSEC source: 0000899243-21-009861 · doc4.xml · nonDerivative · entry 2 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 20,000 Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:05 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 2,146 | $32.45 | $69,637.70 |
DisclosureSEC source: 0000899243-21-009861 · doc4.xml · nonDerivative · entry 1 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 22,854 Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 23:24 UTC |
Fisher DavidDirector · Chief Executive Officer
|
SaleCommon Stock, par value $0.00001 | 32,476 | $30.79 | $999,936.04 |
DisclosureSEC source: 0000899243-21-009489 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,111 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.54 to $31.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:37 UTC |
Chartier KirkChief Marketing Officer
|
GrantCommon stock, par value $0.00001 per share | 24,920 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008936 · doc4.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,960 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:38 UTC |
Fisher DavidDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative | 72,672 | $23.04 Strike: $31.72 | $1,674,362.88 |
DisclosureSEC source: 0000899243-21-008939 · doc4.xml · derivative · entry 2 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,343,667 Underlying: Common stock, par value $0.00001 per share · 72,672 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.50 to $32.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:38 UTC |
Fisher DavidDirector · Chief Executive Officer
|
GrantCommon stock, par value $0.00001 per share | 114,334 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008939 · doc4.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,587 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:42 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 2,000 | $32.00 | $64,000.00 |
DisclosureSEC source: 0000899243-21-008942 · doc4.xml · nonDerivative · entry 1 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 25,000 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:39 UTC |
Cunningham Steven EChief Financial Officer
|
GrantCommon stock, par value $0.00001 per share | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008940 · doc4.xml · nonDerivative · entry 1 Cunningham Steven E · CIK 0001575452 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,549 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:35 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
GrantCommon stock, par value $0.00001 per share | 12,128 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008935 · doc4.xml · nonDerivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,793 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 20:55 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 300 | $29.74 | $8,922.00 |
DisclosureSEC source: 0000899243-21-007562 · doc4.xml · nonDerivative · entry 3 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 27,000 Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 20:55 UTC |
Gray James ADirector
|
SaleCommon stock, par value $0.00001 per share | 263 | $29.73 | $7,818.99 |
DisclosureSEC source: 0000899243-21-007562 · doc4.xml · nonDerivative · entry 2 Gray James A · CIK 0001315492 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · JG 2002 Delta Trust Disclosed balance after: 27,300 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.